Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food industries.
Aplantex has raised $3.7M in total funding. The most recent round was Convertible Note. The last funding was announced in May 2026.
Aplantex's investors include Cycle Momentum, Investissement Quebec, Esplanade Quebec, François Ravenelle, Frederick Perrault.
Aplantex is headquartered in Montréal, Canada.
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food industries.
Aplantex is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aplantex — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/aplantex. Accessed October 28, 2026.
VCBacked. (2026). Aplantex — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/aplantex
{{cite web |title=Aplantex — Funding & Investors |url=https://www.vcbacked.co/company/aplantex |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated